Schrodinger EBIT Margin 2019-2024 | SDGR
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Schrodinger (SDGR) over the last 10 years. The current EBIT profit margin for Schrodinger as of December 31, 2024 is .
| Schrodinger EBIT Margin Historical Data |
| Date |
TTM Revenue |
TTM EBIT |
EBIT Margin |
| 2024-12-31 |
$0.21B |
$-0.21B |
-100.97% |
| 2024-09-30 |
$0.19B |
$-0.22B |
-112.95% |
| 2024-06-30 |
$0.20B |
$-0.21B |
-102.49% |
| 2024-03-31 |
$0.19B |
$-0.21B |
-113.23% |
| 2023-12-31 |
$0.22B |
$-0.18B |
-82.03% |
| 2023-09-30 |
$0.20B |
$-0.18B |
-88.50% |
| 2023-06-30 |
$0.19B |
$-0.17B |
-86.08% |
| 2023-03-31 |
$0.20B |
$-0.15B |
-75.63% |
| 2022-12-31 |
$0.18B |
$-0.15B |
-81.22% |
| 2022-09-30 |
$0.17B |
$-0.14B |
-82.94% |
| 2022-06-30 |
$0.16B |
$-0.13B |
-79.75% |
| 2022-03-31 |
$0.16B |
$-0.12B |
-75.48% |
| 2021-12-31 |
$0.14B |
$-0.11B |
-81.16% |
| 2021-09-30 |
$0.13B |
$-0.11B |
-84.80% |
| 2021-06-30 |
$0.12B |
$-0.09B |
-71.07% |
| 2021-03-31 |
$0.11B |
$-0.07B |
-64.04% |
| 2020-12-31 |
$0.11B |
$-0.06B |
-56.48% |
| 2020-09-30 |
$0.10B |
$-0.05B |
-51.49% |
| 2020-06-30 |
$0.10B |
$-0.05B |
-50.53% |
| 2020-03-31 |
$0.09B |
$-0.05B |
-49.45% |
| 2019-12-31 |
$0.09B |
$-0.04B |
-45.35% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$1.847B |
$0.208B |
|
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
|
